MALIBU, Calif., Feb. 11, 2022 /PRNewswire/ — You can find Dr. Sabine Hazan’s cutting edge article about gut health, "Pain and the Microbiome," in iPain Living Magazine Winter Edition. Dr. Hazan is the author of Let’s Talk Sh!t: Disease, digestion and fecal transplants.
Dr. Hazan, gastroenterologist, clinical researcher and CEO of ProgenaBiome, explores the relationship between gut microbes and their effect on pain in her article "Pain and the Microbiome." Several researchers have found the microbiomes of people suffering from pancreatic cancer, high blood pressure, atherosclerosis, arthritis, Crohn’s disease, inflammatory bowel disease, ulcerative colitis to be distinctively different than those of their healthy counterparts.
There is evidence that bacteria-driven energy sources (metabolites) like short-chain fatty acids are linked to chronic pain and depression. Chemotherapy induced peripheral neuropathy has been associated with low levels of the bacteria Akkermansia muciniphila. Shiro et al., in 2017, found a correlation between stool consistency and pain intensity. High levels of Streptococci have been found in fibromyalgia sufferers.
For more information visit www.ipainliving.org.
ProgenaBiome™ is a genetic research lab whose interest is to understand the clinical implications of the microbiome. Our broad array of specialties allows us to look beyond fecal transplant (refloralization™) to examine other fields of medicine in which dysbiosis could be the culprit of disease. In collaboration with leading physicians in multiple specialties, Progenabiome spearheads the movement of validating, verifying, and clinically applying its sequencing data, to better understand the microbiome.
Contact:
Dr. Sabine Hazan
Founder
Progenabiome
(800) 380-7764
329571@email4pr.com
https://progenabiome.com
SOURCE Sabine Hazan
